Table 1 The proportions of the different sarcoma subtypes of all patients who underwent sarcoma excision from 2004 to 2014 in our University Hospital and of patients who answered life-quality quetionnaire. Subtypes were classified according to WHO classification
All Patients n = 182 | LQ-Patients n = 70 | |
|---|---|---|
Liposarcoma | 36 (20%) | 16 (21%) |
Well differentiated | 21 (11,5%) | 11 (16%) |
De- differentiated | 2 (1%) | 2 (3%) |
Myxoid | 10 (5%) | 2 (3%) |
Pleomorph | 3 (2%) | 1 (1%) |
Undifferentiated pleomorphic sarcoma | 26 (14%) | 7 (10%) |
Synovial sarcoma | 11 (6%) | 5 (7%) |
Fibroblastic/myofibroblastic sarcoma | 43 (24%) | 23 (30%) |
Undifferentiated sarcoma | 33 (18%) | 9 (12%) |
Leiomyosarcoma | 13 (7%) | 7 (9%) |
Rhabdomyosarcoma | 7 (4%) | 2 (3%) |
Extraskeletal chondro−/ osteosarcoma | 5 (3%) | 2 (3%) |
Malignant peripheral nerve sheath tumor | 4 (2%) | 3 (4%) |
Angiosarcoma | 2 (1%) | 0 (0%) |
Other unclassified sarcoma | 2 (1%) | 1 (1%) |